Ether lipid biosynthesis promotes lifespan extension and enables diverse prolongevity paradigms in Caenorhabditis elegans
Data files
Sep 05, 2023 version files 26.29 KB
-
README.md
-
Supplementary_file_2_eLife_2023.xlsx
Abstract
Biguanides, including the world’s most prescribed drug for type 2 diabetes, metformin, not only lower blood sugar but also promote longevity in preclinical models. Epidemiologic studies in humans parallel these findings, indicating favorable effects of metformin on longevity and on reducing the incidence and morbidity associated with aging-related diseases. Despite this promise, the full spectrum of molecular effectors responsible for these health benefits remains elusive. Through unbiased screening in C. elegans, we uncovered a role for genes necessary for ether lipid biosynthesis in the favorable effects of biguanides. We demonstrate that biguanides prompt lifespan extension by stimulating ether lipid biogenesis. Loss of the ether lipid biosynthetic machinery also mitigates lifespan extension attributable to dietary restriction, target of rapamycin (TOR) inhibition, and mitochondrial electron transport chain inhibition. A possible mechanistic explanation for this finding is that ether lipids are required for activation of longevity-promoting, metabolic stress defenses downstream of the conserved transcription factor skn-1/Nrf. In alignment with these findings, overexpression of a single, key, ether lipid biosynthetic enzyme, fard-1/FAR1, is sufficient to promote lifespan extension. These findings illuminate the ether lipid biosynthetic machinery as a novel therapeutic target to promote healthy aging.
Methods
Supplementary file 2 for Cedillo, L., Ahsan, F.M., et al., Ether Lipid Biosynthesis Promotes Lifespan Extension and Enables Diverse Prolongevity Paradigms in Caenorhabditis elegans.
This file contains a dataset from the above manuscript in Microsoft Excel format where C. elegans nematodes (wild type and 3 mutants: fard-1, ads-1, and acl-7) were treated with vehicle or phenformin. Data on 3 biological replicates are included. The file has 3 tabs: 1) Raw mass counts for each identified ether lipid 2) Normalized mass counts for each identified ether lipid 3) Normalized and log10 transformed mass counts for each identified ether lipid The means by which data were normalized are described in the associated methods.
Usage notes
This file can be opened in Microsoft Excel (all versions).